What was Dabur's revenue growth in Q3 FY26?

Dabur reported mid-single digit consolidated revenue growth for Q3 FY26.

Which Dabur segments underperformed in Q3 FY26?

Healthcare and beverages segments reportedly underperformed due to weakness and adverse seasonality.

What are the potential upside risks for Dabur?

Upside risks include stronger rural demand, improved sales in laggard categories, and favorable litigation outcomes.

Home / Business and Economy / Dabur Q3 Update: Mixed Results Amidst Category Weakness

Dabur Q3 Update: Mixed Results Amidst Category Weakness

7 Jan

•

Summary

Dabur reported mid-single digit consolidated revenue growth for Q3 FY26.
Operating profit and PAT growth expected to trail revenue growth.
Weakness in healthcare and adverse seasonality impacted results.

Dabur Q3 Update: Mixed Results Amidst Category Weakness

Dabur has announced its business update for the third quarter of fiscal year 2026, indicating a mid-single digit consolidated revenue increase. The company anticipates that its operating profit and profit after tax will expand at a rate exceeding revenue growth. Domestically, the home and personal care segment demonstrated double-digit revenue growth, while the healthcare division is expected to show sequential improvement, achieving low-single digit growth.

The international business is poised for near double-digit growth when measured in Indian Rupees. Despite these positive indicators, Dabur's performance appears to be below analyst expectations. While the company had guided for mid-to-high single-digit revenue growth in the second half of FY26, the current growth rate falls at the lower end of this range.